Dorota Giersz

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Ejection Fraction

Replacement Therapy

Deep Brain Stimulation

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Paweł Dubiela, Paulina Szymanska-Rozek, Piotr Hasinski, Patryk Lipiński, Grazina Kleinotiene, Dorota Giersz, Anna Tylki-Szymańska
Long- and Short-Term Glucosphingosine (lyso-Gb1) Dynamics in Gaucher Patients Undergoing Enzyme Replacement Therapy. Biomolecules 14 (7) (2024)
Paweł Dubiela, Paulina Szymanska-Rozek, Piotr Hasinski, Patryk Lipiński, Grazina Kleinotiene, Dorota Giersz, Anna Tylki-Szymańska
Long- and Short-Term Glucosphingosine (lyso-Gb1) Dynamics in Gaucher Patients Undergoing Enzyme Replacement Therapy. Biomolecules 14 (7) (2024)
Paweł Dubiela, Paulina Szymanska-Rozek, Piotr Hasinski, Patryk Lipiński, Grazina Kleinotiene, Dorota Giersz, Anna Tylki-Szymańska
Long- and Short-Term Glucosphingosine (lyso-Gb1) Dynamics in Gaucher Patients Undergoing Enzyme Replacement Therapy. Biomolecules 14 (7) (2024)
Paweł Dubiela, Paulina Szymańska-Rożek, Andrzej Eljaszewicz, Patryk Lipiński, Piotr Hasiński, Dorota Giersz, Alicja Walewska, Marlena Tynecka, Marcin Moniuszko, Anna Tylki-Szymańska
Alpha-Synuclein mRNA Level Found Dependent on L444P Variant in Carriers and Gaucher Disease Patients on Enzyme Replacement Therapy. Biomolecules 13 (4) (2023)
Paweł Dubiela, Paulina Szymańska-Rożek, Andrzej Eljaszewicz, Patryk Lipiński, Piotr Hasiński, Dorota Giersz, Alicja Walewska, Marlena Tynecka, Marcin Moniuszko, Anna Tylki-Szymańska
Alpha-Synuclein mRNA Level Found Dependent on L444P Variant in Carriers and Gaucher Disease Patients on Enzyme Replacement Therapy. Biomolecules 13 (4) (2023)
Paweł Dubiela, Paulina Szymańska-Rożek, Andrzej Eljaszewicz, Patryk Lipiński, Piotr Hasiński, Dorota Giersz, Alicja Walewska, Marlena Tynecka, Marcin Moniuszko, Anna Tylki-Szymańska
Alpha-Synuclein mRNA Level Found Dependent on L444P Variant in Carriers and Gaucher Disease Patients on Enzyme Replacement Therapy. Biomolecules 13 (4) (2023)